Conference
FRACTION-RCC: Innovative, high-throughput assessment of nivolumab plus ipilimumab for treatment-refractory advanced renal cell carcinoma (aRCC).
Authors
Choueiri TK; Kluger HM; George S; Tykodi SS; Kuzel TM; Perets R; Nair S; Procopio G; Carducci MA; Castonguay V
Volume
38
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
May 20, 2020
Name of conference
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
Conference place
ELECTR NETWORK
Conference start date
May 29, 2020
Conference end date
May 31, 2020
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
15
ISSN
0732-183X